Yuvimont-LC Syrup is a combination medication containing Levocetirizine 2.5mg and Montelukast 4mg per 5ml, formulated to provide effective relief from allergic conditions. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, blocks the cysteinyl leukotriene receptor, mitigating inflammation and bronchoconstriction commonly observed in asthma and allergic rhinitis. The synergistic action of these agents offers comprehensive management of allergic respiratory disorders by targeting multiple inflammatory pathways. Yuvimont-LC Syrup is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as adjunctive therapy in mild to moderate asthma. It is suitable for pediatric patients requiring combination therapy to control symptoms and improve quality of life. The syrup formulation ensures ease of administration and accurate dosing. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision. Common adverse effects may include headache, drowsiness, and gastrointestinal disturbances. Yuvimont-LC Syrup should be stored at controlled room temperature, protected from light and moisture.